Genmab A/S reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was DKK 16,474 million compared to DKK 14,505 million a year ago. Net income was DKK 4,352 million compared to DKK 5,452 million a year ago.

Basic earnings per share from continuing operations was DKK 66.64 compared to DKK 83.38 a year ago. Diluted earnings per share from continuing operations was DKK 66.02 compared to DKK 82.59 a year ago.